Akari Therapeutics (AKTX) Interest Coverage Ratio (2014 - 2026)
Akari Therapeutics (AKTX) posted quarterly Interest Coverage Ratio of 157.58 for Q1 2026, down 347.04% year-on-year from 63.79 in Q1 2025, and up 97.87% on a QoQ basis from 7404.0 in Q3 2025.
Akari Therapeutics (AKTX) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has reported Interest Coverage Ratio for 10 consecutive years, with 157.58 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio fell 347.04% year-over-year to 157.58 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 146.81 (down 3185.81% YoY) and the FY2025 annual result came in at 0.27, up 23.98% from the prior year.
- Interest Coverage Ratio rose to 157.58 in Q1 2026 per AKTX's latest filing, from 7404.0 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for AKTX reached as high as 0.12 in Q4 2023 and fell as low as 7404.0 in Q3 2025.
- A 4-year average of 997.1 and a median of 38.84 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio slumped 17353.91% — and 2026, when it sank 347.04%.
- Year by year, Interest Coverage Ratio stood at 0.12 in 2023, then plunged by 3218.36% to 4.0 in 2024, then plunged by 185069.42% to 7404.0 in 2025, then jumped by 97.87% to 157.58 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 157.58, 7404.0, and 31.19 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - | -157.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.58 |
| Sep 30, 2025 | -7,404.00 |
| Jun 30, 2025 | -31.19 |
| Mar 31, 2025 | -35.25 |
| Dec 31, 2024 | -4.00 |
| Sep 30, 2024 | -42.42 |
| Dec 31, 2023 | -0.12 |
| Jun 30, 2023 | -302.25 |
| Jun 30, 2021 | -1,082.50 |
| Jun 30, 2020 | -53.54 |
| Jun 30, 2019 | -125.59 |
| Mar 31, 2016 | -0.17 |
| Dec 31, 2015 | 0.19 |
| Sep 30, 2015 | -1.01 |
| Jun 30, 2015 | -502.11 |
| Mar 31, 2015 | -363.18 |
| Dec 31, 2014 | 514.74 |
| Sep 30, 2014 | -75.65 |